WEKO3
AND
アイテム
{"_buckets": {"deposit": "8c6c83a2-8b38-4821-9652-71fe779ba853"}, "_deposit": {"id": "22767", "owners": [], "pid": {"revision_id": 0, "type": "depid", "value": "22767"}, "status": "published"}, "_oai": {"id": "oai:niigata-u.repo.nii.ac.jp:00022767"}, "item_7_alternative_title_1": {"attribute_name": "\u305d\u306e\u4ed6\u306e\u30bf\u30a4\u30c8\u30eb", "attribute_value_mlt": [{"subitem_alternative_title": "Hormone Receptor and Endocrine Therapy for Hormone-dependent Solid Tumors(Receptor Diseases)"}]}, "item_7_biblio_info_6": {"attribute_name": "\u66f8\u8a8c\u60c5\u5831", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "1989-10", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "10", "bibliographicPageEnd": "822", "bibliographicPageStart": "818", "bibliographicVolumeNumber": "103", "bibliographic_titles": [{"bibliographic_title": "\u65b0\u6f5f\u533b\u5b66\u4f1a\u96d1\u8a8c"}, {"bibliographic_title": "\u65b0\u6f5f\u533b\u5b66\u4f1a\u96d1\u8a8c", "bibliographic_titleLang": "en"}]}]}, "item_7_description_4": {"attribute_name": "\u6284\u9332", "attribute_value_mlt": [{"subitem_description": "Hormone therapy plays an important role in the management of hormone-dependent solid tumors. It has the following problems; 1) Using the estrogen and progesterone receptor assays, one can select the group of patients of favorable response to hormone therapy. 2) Response to first hormone therapy frequently predicts response to subsequent therapy. 3) Hormone therapy show an objective response rate of about 30\uff5e40% in any kinds of hormone-dependent solid tumor. 4) Endocrine therapy generally involues less unpleasant side effects than does chemotherapy. 5) Current limitations of endocrine therapy have led to the attempts at refinement of its scheduling such as alternating hormone therapy or combined chemo-endocrine therapy, especialliy in postmenopausal advanced breast cancer patients.", "subitem_description_type": "Abstract"}]}, "item_7_full_name_3": {"attribute_name": "\u8457\u8005\u5225\u540d", "attribute_value_mlt": [{"nameIdentifiers": [{"nameIdentifier": "137938", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Adachi, Isamu"}]}]}, "item_7_publisher_7": {"attribute_name": "\u51fa\u7248\u8005", "attribute_value_mlt": [{"subitem_publisher": "\u65b0\u6f5f\u533b\u5b66\u4f1a"}]}, "item_7_select_19": {"attribute_name": "\u8457\u8005\u7248\u30d5\u30e9\u30b0", "attribute_value_mlt": [{"subitem_select_item": "publisher"}]}, "item_7_source_id_11": {"attribute_name": "\u66f8\u8a8c\u30ec\u30b3\u30fc\u30c9ID", "attribute_value_mlt": [{"subitem_source_identifier": "AN00182415", "subitem_source_identifier_type": "NCID"}]}, "item_7_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "00290440", "subitem_source_identifier_type": "ISSN"}]}, "item_creator": {"attribute_name": "\u8457\u8005", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "\u5b89\u9054, \u52c7"}], "nameIdentifiers": [{"nameIdentifier": "137937", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "\u30d5\u30a1\u30a4\u30eb\u60c5\u5831", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2019-08-19"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "103(10)_818-822.pdf", "filesize": [{"value": "1.4 MB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 1400000.0, "url": {"label": "103(10)_818-822.pdf", "url": "https://niigata-u.repo.nii.ac.jp/record/22767/files/103(10)_818-822.pdf"}, "version_id": "82b9c3a5-4310-4d62-bb80-d5021dee1bc8"}]}, "item_keyword": {"attribute_name": "\u30ad\u30fc\u30ef\u30fc\u30c9", "attribute_value_mlt": [{"subitem_subject": "Hormone-dependent solid tumor", "subitem_subject_scheme": "Other"}, {"subitem_subject": "steroid receptor", "subitem_subject_scheme": "Other"}, {"subitem_subject": "endocrine therapy", "subitem_subject_scheme": "Other"}, {"subitem_subject": "alternating hormone therapy", "subitem_subject_scheme": "Other"}, {"subitem_subject": "combined chemo-endocrine therapy", "subitem_subject_scheme": "Other"}, {"subitem_subject": "\u30db\u30eb\u30e2\u30f3\u4f9d\u5b58\u6027\u60aa\u6027\u816b\u760d", "subitem_subject_scheme": "Other"}, {"subitem_subject": "\u6027\u30db\u30eb\u30e2\u30f3\u30ec\u30bb\u30d7\u30bf\u30fc", "subitem_subject_scheme": "Other"}, {"subitem_subject": "\u5185\u5206\u6ccc\u7642\u6cd5", "subitem_subject_scheme": "Other"}, {"subitem_subject": "\u8907\u5408\u30db\u30eb\u30e2\u30f3\u7642\u6cd5", "subitem_subject_scheme": "Other"}, {"subitem_subject": "\u5185\u5206\u6ccc\u30fb\u5316\u5b66\u7642\u6cd5", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "\u8a00\u8a9e", "attribute_value_mlt": [{"subitem_language": "jpn"}]}, "item_resource_type": {"attribute_name": "\u8cc7\u6e90\u30bf\u30a4\u30d7", "attribute_value_mlt": [{"resourcetype": "departmental bulletin paper", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "6) \u6027\u30db\u30eb\u30e2\u30f3\u30ec\u30bb\u30d7\u30bf\u30fc\u3068\u764c\u306e\u30db\u30eb\u30e2\u30f3\u7642\u6cd5(\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0 \u30ec\u30bb\u30d7\u30bf\u30fc\u3068\u305d\u306e\u81e8\u5e8a, \u7b2c443\u56de\u65b0\u6f5f\u533b\u5b66\u4f1a)", "item_titles": {"attribute_name": "\u30bf\u30a4\u30c8\u30eb", "attribute_value_mlt": [{"subitem_title": "6) \u6027\u30db\u30eb\u30e2\u30f3\u30ec\u30bb\u30d7\u30bf\u30fc\u3068\u764c\u306e\u30db\u30eb\u30e2\u30f3\u7642\u6cd5(\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0 \u30ec\u30bb\u30d7\u30bf\u30fc\u3068\u305d\u306e\u81e8\u5e8a, \u7b2c443\u56de\u65b0\u6f5f\u533b\u5b66\u4f1a)"}, {"subitem_title": "6) \u6027\u30db\u30eb\u30e2\u30f3\u30ec\u30bb\u30d7\u30bf\u30fc\u3068\u764c\u306e\u30db\u30eb\u30e2\u30f3\u7642\u6cd5(\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0 \u30ec\u30bb\u30d7\u30bf\u30fc\u3068\u305d\u306e\u81e8\u5e8a, \u7b2c443\u56de\u65b0\u6f5f\u533b\u5b66\u4f1a)", "subitem_title_language": "en"}]}, "item_type_id": "7", "owner": "1", "path": ["453/456", "471/537/538/1205"], "permalink_uri": "http://hdl.handle.net/10191/41432", "pubdate": {"attribute_name": "\u516c\u958b\u65e5", "attribute_value": "2016-04-12"}, "publish_date": "2016-04-12", "publish_status": "0", "recid": "22767", "relation": {}, "relation_version_is_last": true, "title": ["6) \u6027\u30db\u30eb\u30e2\u30f3\u30ec\u30bb\u30d7\u30bf\u30fc\u3068\u764c\u306e\u30db\u30eb\u30e2\u30f3\u7642\u6cd5(\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0 \u30ec\u30bb\u30d7\u30bf\u30fc\u3068\u305d\u306e\u81e8\u5e8a, \u7b2c443\u56de\u65b0\u6f5f\u533b\u5b66\u4f1a)"], "weko_shared_id": null}
6) 性ホルモンレセプターと癌のホルモン療法(シンポジウム レセプターとその臨床, 第443回新潟医学会)
http://hdl.handle.net/10191/41432
c0e05063-6b54-477e-9ba2-b407934cc079
名前 / ファイル | ライセンス | アクション | |
---|---|---|---|
![]() |
|
Item type | 紀要論文 / Departmental Bulletin Paper(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2016-04-12 | |||||
タイトル | ||||||
タイトル | 6) 性ホルモンレセプターと癌のホルモン療法(シンポジウム レセプターとその臨床, 第443回新潟医学会) | |||||
タイトル | ||||||
言語 | en | |||||
タイトル | 6) 性ホルモンレセプターと癌のホルモン療法(シンポジウム レセプターとその臨床, 第443回新潟医学会) | |||||
言語 | ||||||
言語 | jpn | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Hormone-dependent solid tumor | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | steroid receptor | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | endocrine therapy | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | alternating hormone therapy | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | combined chemo-endocrine therapy | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | ホルモン依存性悪性腫瘍 | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | 性ホルモンレセプター | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | 内分泌療法 | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | 複合ホルモン療法 | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | 内分泌・化学療法 | |||||
資源タイプ | ||||||
資源 | http://purl.org/coar/resource_type/c_6501 | |||||
タイプ | departmental bulletin paper | |||||
その他のタイトル | ||||||
その他のタイトル | Hormone Receptor and Endocrine Therapy for Hormone-dependent Solid Tumors(Receptor Diseases) | |||||
著者 |
安達, 勇
× 安達, 勇 |
|||||
著者別名 | ||||||
識別子 | ||||||
識別子 | 137938 | |||||
識別子Scheme | WEKO | |||||
姓名 | ||||||
姓名 | Adachi, Isamu | |||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Hormone therapy plays an important role in the management of hormone-dependent solid tumors. It has the following problems; 1) Using the estrogen and progesterone receptor assays, one can select the group of patients of favorable response to hormone therapy. 2) Response to first hormone therapy frequently predicts response to subsequent therapy. 3) Hormone therapy show an objective response rate of about 30~40% in any kinds of hormone-dependent solid tumor. 4) Endocrine therapy generally involues less unpleasant side effects than does chemotherapy. 5) Current limitations of endocrine therapy have led to the attempts at refinement of its scheduling such as alternating hormone therapy or combined chemo-endocrine therapy, especialliy in postmenopausal advanced breast cancer patients. | |||||
書誌情報 |
新潟医学会雑誌 en : 新潟医学会雑誌 巻 103, 号 10, p. 818-822, 発行日 1989-10 |
|||||
出版者 | ||||||
出版者 | 新潟医学会 | |||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 00290440 | |||||
書誌レコードID | ||||||
収録物識別子タイプ | NCID | |||||
収録物識別子 | AN00182415 | |||||
著者版フラグ | ||||||
値 | publisher |